News Focus
News Focus
icon url

DewDiligence

11/23/20 8:41 AM

#235815 RE: DewDiligence #235206

MRK submits BLA/MAA for V114 pneumococcal vaccine in adults:

https://finance.yahoo.com/news/merck-submits-applications-licensure-v114-114700204.html

Many investors and analysts think PFE’s Prevnar 20, which covers five more serotypes than V114, will make V114 commercially irrelevant (#msg-154634395).